Sotera Health Company (SHC)
|Net Income (ttm)||-28.48M|
|Trading Day||March 1|
|Day's Range||26.10 - 27.69|
|52-Week Range||24.05 - 29.00|
CLEVELAND, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory ...
CLEVELAND, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory ...
CLEVELAND, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) today announced the closing of its initial public offering (“IPO”) of 53,590,000 shares of its common stock at ...
Sotera Health is a dominant player in sterilization of medical products. The company's products and services are very much in demand, as the company operates in a market which is hard to enter.
Sotera Health raised $1.1 billion with an initial public offering for the provider of medical sterilization, lab testing and advisory services. The Sotera IPO will begin trading Friday.
Shares of Sotera Health Co. started their public life with a rally Friday, as the first trade of the sterilization and lab-testing services provider's stock was 17.4% above the initial-public-...
Shares of Sotera Health Co. are set to start trading Friday, after the Ohio-based sterilization and lab-testing services provider's initial public offering priced at the high end of the expect...
CLEVELAND, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company today announced the pricing of its initial public offering (“IPO”) of 46,600,000 shares of its common stock at a price to the...
Sotera has a stable, predictable and simple business model. Its services are essential and this is reflected in the fact that it has grown revenues every year since 2005.
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. The company also provides Co-60 and gamma irradiators, which are principal components to the gamma sterilization process. Its microbiolo... [Read more...]
Diagnostics & Research
|IPO Date |
Nov 20, 2020
Michael B. Petras Jr.
|Stock Exchange |
|Ticker Symbol |
In 2019, Sotera Health's revenue was $778.33 million, an increase of 4.31% compared to the previous year's $746.15 million. Losses were -$20.85 million, 255.2% more than in 2018.
According to 8 analysts, the average rating for Sotera Health stock is "Buy." The 12-month stock price forecast is 32.31, which is an increase of 17.07% from the latest price.